José Luis Molinuevo spends much of his time researching Disease, Alzheimer's disease, Dementia, Internal medicine and Pathology. His Disease research includes themes of Neurology, Geriatric psychiatry, Physical therapy and Intensive care medicine. His research in Alzheimer's disease intersects with topics in Clinical trial, Psychiatry, Randomized controlled trial, Cognitive test and Biomarker.
His research integrates issues of Epidemiology, Cognition, Cognitive impairment and Clinical psychology in his study of Dementia. His studies in Internal medicine integrate themes in fields like Gastroenterology, Oncology and Geriatrics. His Pathology research integrates issues from Antibody and Transgene.
José Luis Molinuevo focuses on Disease, Internal medicine, Dementia, Pathology and Cerebrospinal fluid. The study incorporates disciplines such as Clinical trial, Gerontology, Intensive care medicine, Biomarker and Neuroscience in addition to Disease. He combines subjects such as Gastroenterology, Endocrinology and Oncology with his study of Internal medicine.
His study in Dementia is interdisciplinary in nature, drawing from both Alzheimer's disease and Psychiatry, Neurology, Cognition. José Luis Molinuevo studies Atrophy which is a part of Pathology. The Cerebrospinal fluid study combines topics in areas such as Csf biomarkers and Neurodegeneration.
His scientific interests lie mostly in Disease, Dementia, Internal medicine, Cognitive decline and Neuroscience. Pathology covers José Luis Molinuevo research in Disease. The various areas that José Luis Molinuevo examines in his Dementia study include Global network, Clinical trial and Gerontology.
His Internal medicine research also works with subjects such as
José Luis Molinuevo mostly deals with Dementia, Disease, Internal medicine, Cerebrospinal fluid and Cognition. José Luis Molinuevo works on Dementia which deals in particular with Cognitive decline. His Disease study frequently links to other fields, such as Cohort study.
His Internal medicine research is multidisciplinary, relying on both Oncology and Cardiology. His Cerebrospinal fluid research includes elements of Biomarker and Preclinical stage. His work on Episodic memory as part of general Cognition research is frequently linked to Air quality index, thereby connecting diverse disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack;David A. Bennett;Kaj Blennow;Maria C. Carrillo.
Alzheimers & Dementia (2018)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
Frank Jessen;Frank Jessen;Rebecca E. Amariglio;Martin van Boxtel;Monique Breteler.
Alzheimers & Dementia (2014)
Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study
Alex Iranzo;José Luis Molinuevo;Joan Santamaría;Mónica Serradell.
Lancet Neurology (2006)
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
Bruno Dubois;Harald Hampel;Harald Hampel;Howard H. Feldman;Philip Scheltens.
Alzheimers & Dementia (2016)
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
Alex Iranzo;Eduard Tolosa;Ellen Gelpi;José Luis Molinuevo.
Lancet Neurology (2013)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis.
Gernot Kleinberger;Yoshinori Yamanishi;Marc Suárez-Calvet;Eva Czirr.
Science Translational Medicine (2014)
Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo;Francisco Lomeña;Heike Stockner;Francesc Valldeoriola.
Lancet Neurology (2010)
Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease.
Cristina Solé-Padullés;David Bartrés-Faz;Carme Junqué;Pere Vendrell.
Neurobiology of Aging (2009)
Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients.
Alex Iranzo;Ana Fernández-Arcos;Eduard Tolosa;Mónica Serradell.
PLOS ONE (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Gothenburg
University of Gothenburg
University of Barcelona
Maastricht University
Vrije Universiteit Amsterdam
University College London
University of Geneva
Vrije Universiteit Brussel
Autonomous University of Barcelona
Vrije Universiteit Amsterdam
University of Virginia
Konya Technical University
Australian National University
Minia University
Technion – Israel Institute of Technology
Chinese Academy of Sciences
Texas A&M University
Tsinghua University
Hebrew University of Jerusalem
University of Colorado Anschutz Medical Campus
Stockholm University
Aberystwyth University
James Hutton Institute
Monash University
University of Pittsburgh
Max Planck Society